Provided by Tiger Fintech (Singapore) Pte. Ltd.

Rallybio Corp.

0.4500
-0.1070-19.21%
Post-market: 0.48000.0300+6.67%19:27 EDT
Volume:183.95K
Turnover:88.32K
Market Cap:18.73M
PE:-0.34
High:0.6325
Open:0.5723
Low:0.4301
Close:0.5570
Loading ...

Promising Preclinical Data and Clinical Advancements Justify Buy Rating for Rallybio

TIPRANKS
·
11 Dec 2024

TD Cowen Keeps Their Buy Rating on Rallybio (RLYB)

TIPRANKS
·
05 Dec 2024

Rallybio price target lowered to $7 from $8 at JMP Securities

TIPRANKS
·
05 Dec 2024

Rallybio Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

Dow Jones
·
03 Dec 2024

Rallybio’s RLYB116: Promising Developments and Buy Rating Driven by Enhanced Manufacturing and Potential in Phase 1 Trials

TIPRANKS
·
03 Dec 2024

BRIEF-Rallybio To Provide Update On Rlyb116 Program

Reuters
·
25 Nov 2024

Rallybio to Provide Update on Rlyb116 Program, an Innovative Subcutaneously Injected C5 Inhibitor

THOMSON REUTERS
·
25 Nov 2024

Rallybio Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

Dow Jones
·
22 Nov 2024

BRIEF-Rallybio Announces Initiation Of Phase 2 Clinical Trial Of RLYB212

Reuters
·
21 Nov 2024

Rallybio Announces Initiation of Phase 2 Clinical Trial of Rlyb212

THOMSON REUTERS
·
21 Nov 2024

Rallybio Corp - Trial to Enroll Participants in Belgium, Netherlands, Norway, Sweden, UK

THOMSON REUTERS
·
21 Nov 2024

Rallybio Corp - Phase 2 Trial to Assess Pk and Safety of Rlyb212

THOMSON REUTERS
·
21 Nov 2024

Rallybio price target lowered to $5 from $6 at H.C. Wainwright

TIPRANKS
·
08 Nov 2024

Rallybio Corporation : H.c. Wainwright Cuts Target Price to $5 From $6

THOMSON REUTERS
·
08 Nov 2024

Rallybio Q3 EPS $(0.26) Beats $(0.37) Estimate, Sales $299.00K

Benzinga
·
07 Nov 2024

BRIEF-Rallybio Q3 Net Income USD -11.466 Million

Reuters
·
07 Nov 2024

Rallybio Q3 Basic EPS USD -0.26

THOMSON REUTERS
·
07 Nov 2024

Rallybio Price Target Maintained With a $6.00/Share by HC Wainwright & Co.

Dow Jones
·
30 Oct 2024

Optimistic Buy Rating for Rallybio Amid Promising Developments in FNAIT Treatment

TIPRANKS
·
30 Oct 2024

Rallybio Gets Clearance for Phase 2 Alloimunization Study in Europe, UK

MT Newswires Live
·
29 Oct 2024